208 related articles for article (PubMed ID: 27467545)
41. Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Pääkkö P; Lappi-Blanco E; Kaarteenaho R
Histopathology; 2017 Sep; 71(3):425-436. PubMed ID: 28401582
[TBL] [Abstract][Full Text] [Related]
42. LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients.
Kim YJ; Hong S; Sung M; Park MJ; Jung K; Noh KW; Oh DY; Lee MS; Oh E; Shin YK; Choi YL
Oncotarget; 2016 Dec; 7(50):82876-82888. PubMed ID: 27756880
[TBL] [Abstract][Full Text] [Related]
43. Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance.
Nakashima H; Jiang SX; Sato Y; Hoshi K; Matsumoto T; Nagashio R; Kobayashi M; Matsuo Y; Shiomi K; Hayakawa K; Saegusa M; Satoh Y
Pathol Int; 2015 Apr; 65(4):183-92. PubMed ID: 25684590
[TBL] [Abstract][Full Text] [Related]
44. The prognostic significance of N-myc downregulated gene 1 in lung adenocarcinoma.
Dai T; Dai Y; Murata Y; Husni RE; Nakano N; Sakashita S; Noguchi M
Pathol Int; 2018 Apr; 68(4):224-231. PubMed ID: 29431240
[TBL] [Abstract][Full Text] [Related]
45. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W
Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791
[TBL] [Abstract][Full Text] [Related]
46. Tumor Spread through Air Spaces Affects the Recurrence and Overall Survival in Patients with Lung Adenocarcinoma >2 to 3 cm.
Dai C; Xie H; Su H; She Y; Zhu E; Fan Z; Zhou F; Ren Y; Xie D; Zheng H; Kadeer X; Chen D; Zhang L; Jiang G; Wu C; Chen C
J Thorac Oncol; 2017 Jul; 12(7):1052-1060. PubMed ID: 28389373
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary Adenocarcinoma.
Warth A; Muley T; Kossakowski CA; Goeppert B; Schirmacher P; Dienemann H; Weichert W
Am J Surg Pathol; 2015 Jun; 39(6):793-801. PubMed ID: 25723114
[TBL] [Abstract][Full Text] [Related]
48. Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.
Maki Y; Soh J; Ichimura K; Shien K; Furukawa M; Muraoka T; Tanaka N; Ueno T; Yamamoto H; Asano H; Tsukuda K; Toyooka S; Miyoshi S
Oncol Rep; 2013 Jan; 29(1):133-40. PubMed ID: 23076555
[TBL] [Abstract][Full Text] [Related]
49. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Yan W; Liang Z; Xiong H; Chen K
Tumour Biol; 2015 Sep; 36(10):8085-92. PubMed ID: 25982999
[TBL] [Abstract][Full Text] [Related]
50. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
[TBL] [Abstract][Full Text] [Related]
51. MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray.
Sang M; Gu L; Yin D; Liu F; Lian Y; Zhang X; Liu S; Huang W; Wu Y; Shan B
J Clin Pathol; 2017 Jun; 70(6):533-540. PubMed ID: 27864450
[TBL] [Abstract][Full Text] [Related]
52. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
[TBL] [Abstract][Full Text] [Related]
53. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
54. Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma.
Oka S; Uramoto H; Shimokawa H; Yamada S; Tanaka F
Oncology; 2014; 86(5-6):263-70. PubMed ID: 24902879
[TBL] [Abstract][Full Text] [Related]
55. Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.
Qu Y; Zhao D; Mu J; Che N; Zhang C; Liu Z; Su D; Zhou L; Zhang H; Wei L
Tumour Biol; 2016 Jan; 37(1):887-96. PubMed ID: 26254613
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.
Cha YJ; Kim HR; Lee CY; Cho BC; Shim HS
Lung Cancer; 2016 Jul; 97():73-80. PubMed ID: 27237031
[TBL] [Abstract][Full Text] [Related]
57. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
[TBL] [Abstract][Full Text] [Related]
58. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
[TBL] [Abstract][Full Text] [Related]
59. β-arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor.
Qiu C; Zheng C; Zhu L; Qu X; Shen H; Du J
Int J Clin Exp Pathol; 2015; 8(4):3785-93. PubMed ID: 26097560
[TBL] [Abstract][Full Text] [Related]
60. Identification of flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis.
Zhang PF; Zeng GQ; Hu R; Li C; Yi H; Li MY; Li XH; Qu JQ; Wan XX; He QY; Li JH; Chen Y; Ye X; Li JY; Wang YY; Feng XP; Xiao ZQ
J Proteomics; 2012 Dec; 77():202-14. PubMed ID: 22982323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
